The prostaglandin D2 antagonist asapiprant ameliorates clinical severity in young hosts infected with invasive Streptococcus pneumoniae.

asapiprant (BGE-175) - BioAge Labs, Shionogi

http://www.ncbi.nlm.nih.gov/pubmed/38629842

Alexsandra Lenhard; Elsa N Bou Ghanem; Fred Aswad; Joshua R Wheeler; Justin Rebo; Kevin Wilhelmsen; Klaus Klumpp; Kristen Fortney; Manmeet Bhalla; Sydney Herring; Yan Wang

Apr 17, 2024